Swedish Moist Snuff and Myocardial Infarction Among Men

  title={Swedish Moist Snuff and Myocardial Infarction Among Men},
  author={Maria-Pia Hergens and Anders Ahlbom and Tomas Andersson and G{\"o}ran Pershagen},
Background: Previous studies have provided inconsistent results on possible increased risk of cardiovascular disease with the use of smokeless tobacco. The aim of this study was to assess whether long-term use of Swedish moist snuff (widely used among Swedish men) increases the risk of acute myocardial infarction. Methods: This case-control study was conducted in 2 Swedish counties. We identified 1760 men, age 45–70 years, who had a myocardial infarction in 1992–1994. We randomly selected male… 

Swedish snuff and incidence of cardiovascular disease. A population-based cohort study

Several life-style risk factors were more prevalent in snuff-users than in non-users and the present study does not support any relationship between snuff and incidence of cardiovascular disease in men.

Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts

Oral moist snuff (snus) is discussed as a safer alternative to smoking, and its use is increasing, and data suggest that use of snus may be associated with a higher risk of heart failure.

Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies

This study does not support any association between use of snus and development of acute myocardial infarction (AMI), and toxic components other than nicotine appear implicated in the pathophysiology of smoking related ischemic heart disease.

Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden

This study has not shown any excess risk among users of snuff for ischaemic heart disease or stroke, and if there is a risk associated with snuff it is evidently much lower than those associated with smoking.

Discontinuation of Smokeless Tobacco and Mortality Risk After Myocardial Infarction

Ending snus use after an MI was associated with a nearly halved mortality risk, similar to the benefit associated with smoking cessation, and these observations suggest that the use of snus after MI should be discouraged.

Circulatory disease and smokeless tobacco in Western populations: a review of the evidence.

  • P. Lee
  • Medicine
    International journal of epidemiology
  • 2007
The overall evidence relating smokeless tobacco (ST) to CID and related risk factors appears to be substantially less than from smoking, and no clear risk from Swedish snuff is seen, but the overall evidence is limited.

Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis

An association was detected between use of smokeless tobacco products and risk of fatal myocardial infarction and stroke, which does not seem to be explained by chance.

Is There Any Association between Use of Smokeless Tobacco Products and Coronary Heart Disease in Bangladesh?

There was no statistically significant association between SLT use in general and CHD among non-smoking adults in Bangladesh, and risk of CHD did not increase with use of individual types except gul, frequency, duration, past use of SLT products, or using the RAQ to re-classify cases and controls.

The STAGE cohort: a prospective study of tobacco use among Swedish twins.

Findings from this study are in contrast to a previously published report on tobacco use among 32,123 Swedish twins 42-64 years old who completed a similar survey, and reported lower rates of snus use at later ages.



Tobacco and myocardial infarction: is snuff less dangerous than cigarettes?

In middle aged mensnuff dipping is associated with a lower risk of myocardial infarction than cigarette smoking, and smoking, but not snuff dipping, predicted myocardia infarctions in a multiple logistic regression model that included age and level of education.

Chronic disease mortality in a cohort of smokeless tobacco users.

Combined use of smokeless tobacco and cigarettes did not increase overall mortality beyond that expected from use of the individual products.

Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large‐scale population survey

Findings indicate that an increased cardiovascular risk is also associated with the use of smokeless tobacco, and smokers showed the lowest prevalence of hypertension.

Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers.

Although the risk of cardiovascular disease associated with the use of smokeless tobacco users and smokers face a higher risk of dying from cardiovascular disease than nonusers, the excess risk gives cause for preventive actions.

A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls

The results suggest that bias from smoker misclassification is likely to be insignificant, and they contribute to the evidence linking exposure to ETS with an increased risk of lung cancer.

Cardiovascular risk factors in young snuff‐users and cigarette smokers

The use of snuff by young men appears to have less impact than smoking on cardiovascular risk factors, with the possible exception of elevated serum insulin and plasma fibrinogen levels.

Does Smokeless Tobacco Cause Hypertension?

Smokeless tobacco use should be considered a potential cause of sodium retention and poor blood pressure control because of its nicotine, sodium, and licorice content.